Clinical-Stage Biotech Stock Might Outperform Amgen Post author:Sam Post published:February 8, 2018 Post category:BioPharma This biotech could potentially could be a better value. Source: BioSpace You Might Also Like Basilea Snags Extended $226M+ Antifungal Deal With Pfizer November 30, 2017 Edwards Lifesciences Gets Split Decision In UK Heart Valve Patent Spat With Boston Scientific March 2, 2017 Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals April 6, 2017
Edwards Lifesciences Gets Split Decision In UK Heart Valve Patent Spat With Boston Scientific March 2, 2017
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals April 6, 2017
